Both VISTA-2 and VISTA-1 demonstrated significant impact of SkQ1 on clearing of Central Corneal Fluorescein Staining (CCFS) and improvement of Best Corrected Visual Acuity (BCVA) at day 28 (p<0.05…(PRWeb February 26, 2021)Read the full story at https://www.prweb.com/releases/mitotech_and_essex_bio_technology_announce_positive_results_of_vista_2_phase_3_clinical_study_in_dry_eye_disease/prweb17752486.htm
Mitotech and Essex Bio-Technology announce positive results of VISTA-2…
by Market Cheetah | Feb 26, 2021 | Benefits Communication, California, Communicable Diseases, Communication, Employment Law, Gender, HR Careers, Human Resources, News, Open Enrollment, Paid Time Off (PTO), Pay Equity